Skip to main content

Table 1 Baseline characteristics

From: Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

 

DOS negative

N = 94 (SD or %)

DOS positive

N = 93 (SD or %)

p

Age

60 (12.9)

68 (11.1)

<.001

Gender

 Male

58 (62%)

66 (71%)

 

 Female

36 (38%)

27 (29%)

.180

Tumor type

 Gastro-intestinal

40 (43%)

28 (30%)

 

 Breast

6 (6%)

6 (7%)

 

 Genito-urethral

23 (25%)

29 (32%)

 

 Skin

4 (4%)

8 (9%)

 

 Lung

0

3 (3%)

 

 Head&neck

5 (5%)

2 (2%)

 

 Brain

0

2 (2%)

 

 Sarcoma

4 (4%)

1 (1%)

 

 Hematological

1 (1%)

9 (10%)

 

 Other

11 (12%)

5 (5%)

.484

Brain metastasis

 No

89 (95%)

87 (94%)

 

 Yes

5 (5%)

6 (6%)

.767

  1. Baseline characteristics of the patients in this study. No statistically significant differences were found except for age; Delirium Observational Scale (DOS) positive patients, who screened positive for delirium with a score ≥ 3 on this scale, tended to be older than DOS negative patients